AstraZeneca and Oxford University aim to have an updated vaccine to address the different CCP virus variants by the autumn, according to an executive for the UK-based drugmaker. Research chief Mene Pangalos said they wanted a next-generation vaccine “as rapidly as possible” to tackle new variants of the Chinese Communist Party (CCP) virus, commonly called…
AstraZeneca Aims to Have Updated Oxford Vaccine for Variants by Autumn
EU Chief Says AstraZeneca Will Deliver 9 Million More Vaccine Doses
AstraZeneca will deliver 9 million more doses of its COVID-19 vaccine to the European Union in the first quarter of this year, making a total of 40 million for the period, and will start deliveries one week earlier than expected, the president of the European Commission said on Sunday. The Anglo-Swedish company unexpectedly announced earlier…
After Outcry, EU Reverses Plan to Restrict Vaccine Exports Through Irish Border
LONDON/BRUSSELS—The European Union on Friday reversed a plan to use emergency Brexit measures to restrict exports of COVID-19 vaccines from crossing the Irish border into the United Kingdom after it sent shockwaves through Northern Ireland, London, and Dublin. In a steep escalation of the EU’s fight to secure vaccine supplies, Brussels had said it would…
AstraZeneca COVID-19 Vaccine Approved in EU; No Age Restriction Amid Uncertainty of Effectiveness in Older People
The European Medicines Agency (EMA) approved the AstraZeneca COVID-19 vaccine as a preventative measure against the disease on Jan. 29 without any restrictions, despite concerns from German experts who say the vaccine lacks sufficient data on people 65 and older. This is the third COVID vaccine approved by the EMA—the European Union’s drug regulator similar…
No Age Restriction for AstraZeneca COVID-19 Vaccine Amid Uncertainty of Effectiveness in Older People
The European Medicines Agency (EMA) has granted authorization for use of the AstraZeneca COVID-19 vaccine as a preventative measure against the disease on Jan. 29 without any restrictions, despite concerns from German experts who say the vaccine lacks sufficient data on people 65 and older. This is the third COVID vaccine approved by the EMA—the…
EU Warns It Could Block Vaccine Exports, Wields Legal Threat at Drugmakers
BRUSSELS—Europe’s fight to secure COVID-19 vaccine supplies intensified on Thursday when the European Union warned drug companies such as AstraZeneca that it would use all legal means or even block exports unless they agreed to deliver shots as promised. The EU, whose member states are far behind Israel, the United Kingdom, and the United States…
UK AstraZeneca Vaccine Plant Partially Evacuated Over Suspect Package
LONDON—A factory in Wales that produces AstraZeneca’s COVID-19 vaccine was partially evacuated on Wednesday after it received a suspicious package and police said a bomb disposal unit was dealing with the incident. Operated by Wockhardt UK, the plant provides so-called fill-and-finish capacity for AstraZeneca’s UK supply chain, which is the final manufacturing step of putting…
Britain Says It Will Work With EU to Avoid Vaccine Disruption
LONDON—Britain will be able to work with the European Union to ensure there is no disruption to vaccine supplies, Health Minister Matt Hancock said on Tuesday, arguing protectionism was not right during a pandemic. German Health Minister Jens Spahn earlier said he backed proposals to restrict vaccines leaving the EU, saying Europe should have its…
Stick to Your Word, EU Tells Vaccine Makers, as Supply Chains Wobble
VILNIUS—Europe urged pharmaceutical companies on Tuesday to stand by their word in supplying coronavirus vaccines amid a series of delivery cuts and delays, as hopes for a quick fix to COVID-19 slowly crumble into recrimination. The world has hailed the super-fast development of vaccines as the best chance of escaping the year-long pandemic, which has…
US Approval of AstraZeneca, Johnson & Johnson Vaccines Likely ‘Weeks Away’: Fauci
A COVID-19 vaccine developed by Johnson & Johnson, and another by AstraZeneca and Oxford University, are likely “weeks away” from being presented to U.S. regulators for approval, Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, said Sunday. “We’re weeks away, not months away, for sure,” said Fauci, speaking on NBC’s “Meet…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`